NCT00761436View on ClinicalTrials.gov

Pilot Study of Safety and Efficacy of Spheramine

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

May 14, 2012

Study Completion Date

May 14, 2012

Conditions
Parkinson''s Disease
Interventions
BIOLOGICAL

Spheramine (BAY86-5280)

Stereotactic Intrastriatal Implantation

Trial Locations (1)

30329

Atlanta

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

Titan Pharmaceuticals
All Listed Sponsors
collaborator

Titan Pharmaceuticals

INDUSTRY

lead

Bayer

INDUSTRY